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ABSTRACT
The diversity of T-cell populations is determined by
the spectrum of antigen-specific T-cell receptors
(TCRs) that are heterodimers of a and b subunits
encoded by rearranged combinations of variable
(AV and BV), joining (AJ and BJ), and constant
region genes (AC and BC). We have developed a
novel approach for analysis of b transcript diversity
in mice with a real-time PCR-based method that
uses a matrix of BV- and BJ-specific primers to
amplify 240 distinct BV–BJ combinations. Defined
endpoints (Ct values) and dissociation curves are
generated for each BV–BJ combination and the
Ct values are consolidated in a matrix that charac-
terizes the b transcript diversity of each RNA
sample. Relative diversities of BV–BJ combinations
in individual RNA samples are further described by
estimates of scaled entropy. A skin allograft system
was used to demonstrate that dissection of reper-
toires into 240 BV–BJ combinations increases
efficiency of identifying and sequencing b tran-
scripts that are overrepresented at inflammatory
sites. These BV–BJ matrices should generate
greater investigation in laboratory and clinical set-
tings due to increased throughput, resolution and
identification of overrepresented TCR transcripts.
INTRODUCTION
The diversity of T-cell repertoires is dependent on the
range of combinations of unique a and b subunits that
determine the antigenic speciﬁcity of T-cell receptors
(TCRs). This speciﬁcity is determined by the utilized vari-
able (V) and joining (J) regions in a and b subunits as
well as the diversity (D) regions in b subunits (1).
Recombinations between V and J gene segments result
in the formation of complementarity-determining region
3s (CDR3s) that include the carboxy and amino termini of
the V and J segments, respectively, as well as variable
numbers of random nucleotides inserted between the
V and J segments. CDR3s impact antigenic speciﬁcity
through their lengths and amino acid sequences (2–5)
that contact the amino and carboxy termini of peptides
that are bound to the products of major histocompatibil-
ity complex (MHC) class I and class II genes (6). Analysis
of the diversities of TCR repertoires has been aimed at
(i) quantitating the diversity of a and b transcripts
within T-cell populations and (ii) identifying and sequen-
cing overrepresented TCR transcripts. A number of meth-
ods have been developed to evaluate diversity through
quantitation of the speed and eﬃciency of rehybridization
of denatured PCR products from populations of b tran-
scripts (7,8) and hybridization of cRNA from b transcripts
to arrays of expressed sequence tags from human genes
(9). The identiﬁcation of overrepresented TCR transcripts
involves (i) the cloning and sequencing of b transcript
sequences from selected populations of cDNA or PCR
products and/or (ii) the cloning of T cells followed by
ampliﬁcation and sequencing of TCR transcripts.
The only experimental platform that both evaluates
TCR diversity and identiﬁes prominent b transcripts is
spectratyping, or immunoscope, that is based on the
observations that transcripts carrying a single BV or AV
gene segment normally include CDR3s that exhibit
Gaussian distributions of length. This method involves
reverse transcriptase-polymerse chain reaction (RT–
PCR) ampliﬁcation of a and b transcripts using V gene-
speciﬁc forward primers and a constant region reverse
primer followed by electrophoretic separation of ampli-
cons for the display of distributions of CDR3 lengths
(10–12). Spectratyping has been useful for two purposes:
(i) evaluation of diversity since TCR transcripts from
normal T-cell populations display Gaussian distributions
of CDR3 lengths whereas amplicons from selected popu-
lations can exhibit reductions in variability of CDR3
lengths due to restrictions in diversity and/or antigen-
driven expansion of speciﬁc T cells (12) and (ii) identiﬁca-
tion of amplicons with single CDR3 lengths for direct
sequencing that can be successful if a single amplicon
is present for a single V gene primer (12–14). BJ-speciﬁc
primers have been selected for increased resolution
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these BV–BJ re-ampliﬁcations have not been utilized for
the routine analysis of TCR diversity. The identiﬁcation
and sequencing of overrepresented transcripts at inﬂam-
matory sites, tumors, and transplanted organs, can
provide important data for understanding the diversity
of T-cell populations at those sites as well as characteris-
tics of CDR3 regions expressed by the overrepresented
T cells.
Despite the capacity of spectratyping to both evaluate
diversity and antigen-driven selection, technical complex-
ities appear to have limited its wide-spread application,
as evidenced by the drive to develop the alternative,
hybridization-based approaches described above (7–9).
Methods that utilize quantitative (real-time) RT-PCR
have more recently been developed to quantitate the rela-
tive percentages of T cells that express individual BV genes
(17,18), but these methods lack the resolution required
to eﬀectively evaluate repertoire diversity and eﬃciently
identify overrepresented transcripts due to their BV
gene-speciﬁc ampliﬁcations. The capacity of real-time
PCR methodology to simultaneously monitor ampliﬁca-
tion in multiple reactions with high sensitivity oﬀers an
opportunity to develop TCR repertoire analysis with
improved levels of resolution, speed and cost. In this com-
munication, we describe a real-time PCR method that is
designed to individually and simultaneously amplify all
240 BV–BJ combinations expressed by murine T cells.
The increased complexity of this matrix of 240 combina-
tions increases the resolution of the analysis of repertoire
diversity as well as the eﬃciency of identiﬁcation and
sequencing of overrepresented transcripts.
MATERIALS AND METHODS
Mice
C57Bl/10SnJ (B10), C57BL/6J (B6), B10.129-H4
b (21M),
and NOD.CB17-Prkdc
scid/J (NOD-scid) mice were pur-
chased from the Jackson Laboratory (Bar Harbor, ME).
BALB/c-nude mice were purchased from Taconic Farms,
(Germantown, NY, USA). All mice were housed in
the barrier facility in the Mayo Clinic Department of
Comparative Medicine, and all mice were raised and
maintained with protocols approved by the Institutional
Animal Care and Use Committee of the Mayo Clinic.
Cell harvests and skingrafting
Lymphocyte populations were suspended by pressing
spleens through nylon bolting cloth (100mm pore size);
lymphocytes were resuspended in lysis buﬀer (RNeasy
Protect MiniKit, Qiagen, Valencia, CA, USA) for storage
at  80
8C. T cells were enriched from spleen cell suspen-
sions from nude mice by panning over dishes coated with
aﬃnity-puriﬁed goat anti-mouse immunoglobulin as pre-
viously described (19). Transplantation of orthotopic tail
skin grafts ( 2 5mm
2 in size) was performed according
to the previously described technique (20). All skin graft-
ing was performed with donors and recipients that were
anesthetized with sodium pentobarbital. Each recipient of
primary allografts received a single autograft and two
allografts. Second through ﬁfth sets of two skin allografts
were transplanted  14 days after rejection of the preced-
ing set of allografts. Fifth set grafts were harvested during
the process of rejection, and harvested grafts were imme-
diately transferred to lysis buﬀer for storage at  80
8C.
Experimental methodfor btranscript amplification
Murine TCR b transcript repertoires include transcripts
that result from rearrangements between 21 BV and 12
BJ gene segments. The described method ultimately
involves the simultaneous ampliﬁcation of 240 BV–BJ
combinations by real-time PCR using 20 BV- and 12 BJ-
speciﬁc primers (Figure 1). Brieﬂy, b transcripts are ﬁrst
reverse-transcribed from total RNA with a biotinylated
BC region reverse primer and ampliﬁed with pools of
BV-speciﬁc forward primers. The resulting amplicons are
mixed with streptavidin-coated magnetic beads to enrich
products that include the biotinylated BC region primer.
The bead-enriched products are delivered to microtiter
wells for ampliﬁcation in real-time PCR using 240
nested BV–BJ primer pairs.
Extraction of total RNA
Total RNA was extracted from suspended splenocytes and
tail skin grafts from individual mice using an RNeasy
Protect MiniKit (Qiagen) according to the manufacturer’s
instructions. Approximately 0.6 mg and 1.5–5.0 mg total
RNA were extracted per million splenocytes and two
skin grafts, respectively. Residual genomic DNA was
removed from extracted RNA samples using an RNase-
Free DNase Set (Qiagen). Total RNA was diluted to
5ng/ml in water immediately prior to use in RT–PCRs.
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Figure 1. Schematic diagram of pooled RT–PCRs and BV–BJ-speciﬁc real-time PCRs.
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The RT–PCRs and real-time PCRs required the following
primers: (i) a reverse BC region primer that was biotiny-
lated at the 50- end, (ii) a pair of nested forward primers
speciﬁc for each of the 21 individual BV genes and (iii) a
set of reverse primers speciﬁc for the 12 individual BJ
genes (Table 1). Sequences of 21 forward, outer BV pri-
mers are homologous to sequences within the CDR1
regions of BV genes, and these primers are divided into
four primer pools based on relative homologies. Twenty
nested BV primers are based on sequences within the
CDR2 regions. The relatively high homology between
BV8.1 and BV8.2 genes was problematic for discriminat-
ing ampliﬁcation. Although the BV8.1- and BV8.2-speciﬁc
primers for RT–PCRs were distinguished by two nucleo-
tide substitutions in the ﬁrst four nucleotides at the 30-
ends, we were not conﬁdent of their capacities to distin-
guish BV8.1 and BV8.2 genes. Considering the technical
complexities in setting up real-time PCRs with such a large
matrix, we chose to place the BV8.1- and BV8.2-speciﬁc
outer primers in the same pool for RT–PCRs and
co-amplify them with a single inner primer in real-
time PCRs. All primers were synthesized by the
Invitrogen (Carlsbad, CA,USA) Supply Center located
at the Mayo Clinic Primer Core Facility (Rochester,
MN, USA). The biotinylated BC region reverse primer
was diluted to 20 mM in water. Outer, forward BV primers
for RT–PCRs were mixed in four pools: three pools of
ﬁve primers and one pool of six primers. The concentra-
tion of each primer in a pool was adjusted to 6.6 mMi n
water. BV- and BJ-speciﬁc primers for real-time PCRs
were diluted to 10 mM in water.
RT–PCRs
RNA templates were denatured at 758C for 4min and
placed on ice prior to addition to RT–PCR reactions.
Four pooled RT–PCRs were performed in 25 ml volumes
using (i) a master mix from a one-step RT–PCR Kit
(Qiagen; 20 ml), (ii) 15ng of denatured total RNA (3 ml),
(iii) 20 pmol of a 50-biotinylated BC primer (1 ml) and
(iv) 6.6 pmol of each of the pooled BV primers (1 mlo f
pooled primers). RT–PCRs were performed on a PTC-225
Peltier Thermal Cycler (MJ Research, Waltham, MA,
USA) as follows. cDNA was synthesized at 508C for
32min followed by incubation at 958C for 15min to
inactivate the reverse transcriptase. Subsequent PCR
Table 1. Sequences of oligonucleotide primers used for ampliﬁcations in pooled RT–PCRs and real-time PCRs
RT–PCR primers
Constant region reverse primer: Bio-GCAATCTCTGCTTTTGATGGCT (Biotinylated at 50-end)
Pool #1: Pool #2:
BV1 TATGTCTTGTGGAAACAGCACTC BV4 GAAAAAATCCTGATATGCGAACAGTA
BV2 ATGGCTTCTGTGGCTACAGACC BV6 CAAAAACTGACCTTGAAATGTCAA
BV5.1 AACACTGCCTTCCCTGACCC BV7 AGAATGTTTTGCTGGAATGTGGA
BV5.2 GTCTAACACTGTCCTCGCTGATTC BV11 TGCTTCTTGAGAGCAGAACCAA
BV8.3 GAAAGGTGACATTGAGCTGTCAC BV12 CAATAATCCTGAAGTGTGAGCCAG
Pool #3: Pool #4:
BV3 AAGGACAAAAAGCAAAGATGAGG BV8.1 GAAAGGTGACATTGAGCTGTCAC
BV14 CCTGGGCATGTTCTTGGG BV8.2 GGAAAGGTGACATTGAGCTGTAAT
BV15 TATTACTTCTGGGGCCTG BV9 CTTCTGTCTTCTTGCAGCCACTT
BV16 GTTGGATAATTTTTAGTTTCTTGGAAG BV10 TGCCTCTTGGGAATAGGCC
BV20 GGCCAGGAAGCAGAGATGAAA BV13 AGTGTTCTGTCTCCTTGACACAGTAC
BV18 CCTGCTACTTCTTTGGAGCCA
Real-time PCR primers
Nested BV primers BJ primers
BV1 GCCCAGTCGTTTTATACCTGAAT BJ1.1 CTGGTTCCTTTACCAAAGAAGACT
BV2 GTGCTGATTACCTGGCCACAC BJ1.2 CCCTGAGCCGAAGGTGTAGTC
BV3 GAAAAACGATTCTCTGCTGAGTGT BJ1.3 TTCTCCAAAATAGAGCGTATTTCC
BV4 CTTATGGACAATCAGACTGCCTCA BJ1.4 GGTTCCATGACCGAAAAATAATCT
BV5.1 ATGGAGAGAGATAAAGGAAACCTG BJ1.5 CTCCAAAAAGCGGAGCCTG
BV5.2 GTGGAGAGAGACAAAGGATTCCTA BJ1.6 CGCAAAGTAGAGGGGCGAA
BV6 GGCGATCTATCTGAAGGCTATGA BJ2.1 CTGGTCCGAAGAACTGCTCA
BV7 AAGGAGACATCCCTAAAGGATACAG BJ2.2 CCAAAGTAGAGCTGCCCGGT
BV8.1+2 CAAGGCCTCCAGACCAAGC BJ2.3 CCTGAGCCAAAATACAGCGTT
BV8.3 ACAAGGCCACCAGAACAACG BJ2.4 GCACCAAAGTACAAGGTGTTTTG
BV9 TTCTACTATGATAAGATTTTGAACAGGG BJ2.5 GGCCCAAAGTACTGGGTGTC
BV10 GGCGCTTCTCACCTCAGTCTT BJ2.7 GCCGGGACCGAAGTACTGT
BV11 AGATGATTCAGGGATGCCCA
BV12 CAAGTCTCTTATGGAAGATGGTGG
BV13 GATGAG GCTGTTATAGATAATTCACAGT
BV14 CAGGTAGAGTCGGTGGTGCAA
BV15 CAGGAAAAATTTCCCATCAGTCAT
BV16 GGAGAAGTCTAAACTGTTTAAGGATCAG
BV18 AAGGACAAGTTTCCAATCAGCC
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728C for 25 cycles. A ﬁnal extension cycle was performed
for 6min at 728C. RT–PCR products were separated
from residual primers and ampliﬁcation reagents using
a QIAquick PCR Puriﬁcation Kit (Qiagen) and eluted
with 50 ml of elution buﬀer.
Enrichment ofbiotinylated PCR products
Biotinylated RT–PCR products were enriched with mag-
netic My One
TM Streptavidin C1 Dynabeads (Dynal
Biotech ASA, Oslo, Norway) using the manufacturer’s
magnet and protocol. For each RT–PCR product, 50 ml
of Dynabeads were washed 2-times in 50 mlo f2   washing
and binding buﬀer [10mM Tris–HCl (pH 7.5), 1mM
EDTA, and 2M NaCl]. The washed beads were resus-
pended in 100 mlo f2   washing and binding buﬀer and
added to 50 ml of sterile water and the RT–PCR product
(50 ml). The bead+product suspensions were gently
shaken at room temperature for 15min. The product-
bound beads were washed twice with 100 mlo f1   washing
and binding buﬀer and then resuspended in 100 mlo f
10mM Tris–HCl, pH 8.5. Suspensions of amplicon-
bound beads were diluted 1:10 immediately prior to use
as templates in real-time PCR reactions.
Real-timePCR
A total of 240 individual real-time PCRs (20 BV and 12 BJ
primers) were performed in 10 ml volumes in 384-well
Clear Optical Reaction Plates with Optical Adhesive
Covers (Applied Biosystems, Foster City, CA, USA).
The components of reactions were (i) 5 ml of Power
SYBR Green PCR Master Mix (2 ) (Applied
Biosystems), (ii) 1 ml of the respective amplicon-bound
bead suspension, (iii) 10 pmol of a nested BV primer (1
ml) and (iv) 10 pmol of a BJ-speciﬁc primer (1 ml) and 2 ml
of nuclease-free water (Qiagen). Cycling was performed on
an ABI Prism 7900HT Sequence Detection System at the
AGTC Microarray Shared Resource Core Facility (Mayo
Clinic Rochester, MN, USA) using SYBR Green detec-
tion. Cycling parameters were as follows: (i) an initial
incubation at 508C for 2min, (ii) a 10min incubation at
958C to activate the DNA polymerase and (iii) 40 cycles of
15s at 958C followed by 1min at 608C. Dissociation
curves were generated by (i) incubating the amplicons at
958C for 15s, (ii) reducing the temperature to 608C for 15s
and (iii) increasing the temperature to 958C over a disso-
ciation time of 20min. Data were analysed with the
7900HT Sequence Detection System (SDS) Version 2.3
software (Applied Biosystems) to estimate cycle threshold
(Ct) values and dissociation curves to estimate the optimal
melting temperatures for all reactions. Ct values are frac-
tional cycle numbers at which ﬂuorescence equals the
threshold level (designated by a horizontal line in Ct
plots), that is automatically set to be within the exponen-
tial region of the ampliﬁcation curve where there is a linear
relationship between the log of change in ﬂuorescence and
cycle number. Dissociation curves are formed by plotting
rising temperatures versus the change in ﬂuorescence/
change in temperature.
Sequence analysis
Real-time PCR products were cleaned using a QIAquick
PCR Puriﬁcation Kit prior to sequencing with 2 pmol of
the respective, nested BV primers. Sequencing was per-
formed by the Mayo Clinic Molecular Biology Core
Facility using a Big Dye Terminator v1.1 Cycle
Sequencing Kit (Applied Biosystems) prior to sequence
analysis with a 96-capillary ABI PRISM
TM 3730 XL
DNA Analyzer (Perkin Elmer Applied Biosystems,
Foster City, CA, USA) by the Mayo Clinic Molecular
Biology Core Facility.
Statistical analysis
The relative abundance of BV–BJ combinations was
deﬁned by the observed Ct values. Dissociation curves
were used to conﬁrm the presence of amplicons from b
transcripts by excluding (i) primer-dimers that had rela-
tively low melting temperatures and (ii) amplicons with
dissociation peak heights that did not exceed a threshold
of 0.07 (change in ﬂuoresence/change in temperature).
This threshold was selected experimentally due to the
inability to sequence amplicons that were below this
value. Amplicons with either or both of these character-
istics were assigned Ct values of >40 cycles. The diversities
of the 240 BV–BJ combinations within individual RNA
templates were estimated by Shannon entropy (21) that
has been used for estimating variability at individual
amino acid positions in immunoglobulin variable region
(V) gene products (22). An estimate of scaled entropy (H)
was calculated for each BV–BJ matrix by the equation
H=(P log2P)/log2(1/240) where P was the probability
of abundance calculated for each BV–BJ combination
by the equation P=2
 y/2
 y where y was the Ct value
for the BV–BJ primer pair and P=0 when Ct > 40
cycles.Scaled entropy ranges from 0 to 1 with 1 represent-
ing maximal diversity.
RESULTS
Experimental method
The diversity of expressed combinations of individual BV
and BJ genes is a major contributor to the diversity of
TCR repertoires. Two hundred and ﬁfty-two BV–BJ com-
binations can be expressed in mice based on 21 BV and
12 BJ genes. A real-time PCR matrix was developed to
evaluate expression of transcripts carrying 240 diﬀerent
BV–BJ combinations using 20 BV primers and 12 BJ pri-
mers. The BV8.1 and BV8.2 genes were grouped together
due to their relatively high level of homology. The ﬂow of
the experimental method is presented in Figure 1.
Templates for real-time PCRs were ampliﬁed in four
pooled RT–PCRs using (i) total RNA as template, (ii) a
reverse constant region primer that was biotinylated at the
50 end and (iii) four pools of ﬁve to six BV-speciﬁc primers.
RT–PCRs were performed with pooled BV primers to
conserve total RNA, and BV-speciﬁc primers were
placed in pools on the basis of relative homology to mini-
mize cross-priming. Excess primers were washed from
ampliﬁed products by direct column puriﬁcation prior
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enrich products carrying the biotinylated BC primer.
Bead-based enrichment of RT–PCR products was
included in the method rather than simple dilution of
the products since it was shown to increase speciﬁcity in
the downstream real-time PCRs (data not shown), pre-
sumably due to the elimination of non-speciﬁc products
derived from non-speciﬁc pairing of the pooled BV
primers.The selections of numbers of cycles in RT–PCRs
and the extent of dilution of bead-enriched products were
interrelated and determined by (i) the numbers of BV–BJ
primer pairs for real-time PCRs, (ii) the range in represen-
tation of transcripts carrying diﬀerent BV–BJ com-
binations and (iii) the minimization of the numbers
of amplicon-bound beads added to real-time PCRs.
Amplicon-bound beads were diluted and aliquoted into
the wells of 384-well plates along with 240 combinations
of nested BV- and BJ-speciﬁc primers.
Ampliﬁcation was monitored by the uptake of SYBR
Green with automated estimation of Ct values throughout
each reaction. Dissociation curves were generated after the
ﬁnal ampliﬁcation cycle by increasing.the temperature
from 60–958C. The selection of SYBR Green to monitor
ampliﬁcation was based on the diﬃculty and expense in
designing and synthesizing ﬂuorochrome-labeled probes
for individual BV genes. SYBR Green also allows analyses
of dissociation peak shapes to visually distinguish pro-
ducts of single and multiple transcripts. Lack of speciﬁc
ampliﬁcation was concluded if: (i) SYBR Green uptake
had not reached the threshold for estimation of a Ct
value: (ii) there had been a low melting temperature that
was not characteristic of b transcript products: or (iii)
heights of dissociation peaks did not exceed a threshold
of 0.07 (change in ﬂuorescence/change in temperature).
In such cases, Ct values of >40 cycles were assigned.
TCR repertoires in normalmice
BV–BJ matrices were ﬁrst used for the analysis of b tran-
script repertoires in lymphocyte populations from normal
mice. The data presented in Figure 2A were derived from
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Figure 2. Distribution of Ct values from 240 BV–BJ combinations and reproducibility of BV–BJ-speciﬁc ampliﬁcation. (A) Representation of the
distribution of Ct values using total RNA template extracted from normal B6 splenocytes. Histograms of the distributions of Ct values from (A) (B)
and two replicate ampliﬁcations (C and D) of the same RNA template with notations of the mean Ct values and 95% conﬁdence intervals (CIs) of the
means. (E) Mean Ct values and 95% CIs for pairwise comparisons of Ct values from 240 BV–BJ combinations in the three replicate ampliﬁcations.
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harvested from a single B6 mouse; 15ng RNA were used
for each pooled RT–PCR. Ct values were estimated for
each BV–BJ combination, taking into consideration the
dissociation curves to conﬁrm the ampliﬁcation of b tran-
scripts and exclude primer-dimers based on the curves of
melting temperatures. The threshold for Ct value estima-
tion was reached with all BV–BJ combinations and all
melting curves were consistent with ampliﬁcation of b
transcripts. The vast majority of Ct values (95%) were
between 16 and 24 cycles (Figure 2A and B). These results
demonstrate that all 240 BV–BJ combinations can be
ampliﬁed with the utilized primer sets.
Ampliﬁcation in a total of 25 RT–PCR cycles and 40
real-time PCR cycles requires careful attention to potential
sources of experimental error. Two additional replicate
assays were performed with the same source of RNA tem-
plate to evaluate reproducibility (Figure 2C and D). The
mean Ct values for the replicate matrices (19.57 and 19.64)
were virtually identical to that of the original matrix
(19.48 cycles) with comparable distributions. The replicate
distributions of Ct values were also compared by calculat-
ing (i) the delta Ct (Ct) values between individual, repli-
cate BV–BJ combinations and (ii) the mean Cts for all
three comparisons of replicate matrices. The mean Cts
ranged from 0.32 to 0.37 (Figure 2E), and these ranges
are well within the sensitivity range of  0.5 cycles reported
with the use of gene expression master mixes for
real-time PCR (personal communication, Applied
Biosystems). The eﬀects of diﬀerent lymphocyte sources
of total RNA on the reproducibility of results from BV–
BJ matrices can be assessed by comparing the mean Ct
values, described in Figures 2–5, that were obtained with
RNA extracted from splenocytes harvested from multiple
C57 background mice.
The ampliﬁcation of b transcripts with outer BV pri-
mers in RT–PCRs increases the speciﬁcity of ampliﬁca-
tions in fully nested BV–BJ-speciﬁc real-time PCRs.
However, RT–PCR ampliﬁcations through 25 cycles
could potentially lead to saturated product levels which
could distort the distributions of b transcript products
and, therefore, alter the results of the BV–BJ matrix.
Therefore, we investigated the eﬀects of reducing the
number of RT–PCR cycles on mean Ct values from BV–
BJ primer pairs in real-time PCRs. RNA template (15ng)
from normal B6 splenocytes was ampliﬁed for 20 and
25 cycles in RT–PCRs. Ampliﬁed products were bead-
enriched and ampliﬁed with 180 BV–BJ primer pairs in
real-time PCRs. The reduction of the RT–PCRs to 20
cycles resulted in an increase in mean Ct value of 4.3
cycles (Figure 3). These results suggested that the accumu-
lation of products in the RT–PCRs was not saturated over
the 20–25 cycle range.
Effects ofdilutions of templates forRT–PCRs and real-time
PCRs
BV–BJ primer pairs with comparable eﬃciencies are
important for maximal detection of transcripts with
variable levels of representation. Comparable primer
pair eﬃciencies should yield comparable increases in
Ct values following dilution of templates for real-time
PCRs. Pooled RT–PCRs were performed and the bead-
enriched products from each pooled RT–PCR were used
in real-time PCRs undiluted (as per standard protocol)
and diluted 1/4 and 1/16 (Figure 4). A 1/4 dilution resulted
in a mean increase of 1.29 cycles and a 1/16 dilution
resulted in an additional mean increase of 1.68 cycles
(Figure 4A–C). More importantly, >90% of the BV–BJ
combinations exhibited Ct values in the 1.0–1.75 cycle
interval in the undiluted versus 1/4 comparison, and, like-
wise, >90% of the combinations showed Ct values in the
1.25–2.00 interval for the 1/4 versus 1/16 comparison
(Figure 4D and E). Further, no consistent eﬀect of titra-
tion (undiluted ! 1/16) was observed for the <10% of
BV–BJ combinations whose Ct values fell outside of
these ranges suggesting that these shifts were not due to
reproducible diﬀerences in BV–BJ primer pair eﬃciences.
Normal T-cell populations exhibit variable levels of
expression of both BV and BJ genes (23–26), and it
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RNA template for the BV–BJ matrix results in the loss
of detection of transcripts that carry BV–BJ combinations
that are low in abundance. The data presented above sug-
gest that the speed of ampliﬁcation in the real-time PCR
phase of the BV–BJ matrix method is directly related to
the amount of bead-enriched template. However, the Ct
values in the BV–BJ matrix are the product of ampliﬁca-
tion in both the real-time PCRs as well as the pooled
RT–PCRs. Predictably, the RT–PCRs are more complex
reactions given the heterogeneous template and pooled
BV primers that potentially could result in non-speciﬁc
ampliﬁcation and competition between BV primers
for ampliﬁcation with the biotinylated BC primer.
Accordingly, these ampliﬁcations may be more sensitive
to variations in amounts of template RNA.
We investigated the eﬀects of RNA titration on
ampliﬁcation with BV–BJ primer pairs. Total RNA was
extracted from B6 splenocytes and ampliﬁed in pooled
RT–PCRs after either no dilution or 1/4 and 1/16 dilu-
tions. Bead-enriched templates were then ampliﬁed in
real-time PCRs to evaluate the eﬀects of RNA template
dilution on mean Ct values and Ct values for individual
BV–BJ primer pairs. Reductions in amounts of RNA tem-
plate resulted in increases in mean Ct values (Figure 5A–
C) with increased tailing toward higher Ct values with
extended (1/16) dilution. Further, the breadths of the
major peaks of Ct values were increased following dilu-
tion (Figure 5D and E) over those observed with 1/4 and
1/16 dilutions of bead-enriched templates for real-time
PCRs (Figure 4D and E). The increases in Ct variability
are not unexpected given that template dilutions were
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Figure 4. Eﬀects of titration of products of pooled RT–PCRs on BV–BJ-speciﬁc ampliﬁcation in real-time PCRs. b transcripts in total RNA from B6
splenocytes were ampliﬁed in pooled RT–PCRs and speciﬁc amplicons were enriched with magnetic beads. Enriched products were ampliﬁed in BV–
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template and multiple, pooled BV primers. This increased
variability extended further to a minority (<10%) of BV–
BJ combinations that exhibited Ct values (1/4 versus 1/
16) that exceeded those expected for a 4-fold dilution. A
close examination of the Ct values for these BV–BJ com-
binations revealed that there was no clear correlation
between the Ct values with 1/4 diluted template and
their Ct values (1/4 versus 1/16). We investigated the
eﬀects of RNA template dilution on Shannon entropy
estimates of diversity and calculated scaled entropy
values of 0.86, 0.85 and 0.81 for the undiluted, 1/4 diluted
and 1/16 diluted RNA templates, respectively. The
estimated loss in diversity with increasing template
dilution (1/16) appeared to be due to a small number of
BV–BJ primer pairs that yielded no ampliﬁcation (Ct>40
cycles).
Considering the results of titrations of both bead-
enriched template and starting RNA template, it is appar-
ent that ampliﬁcations with the vast majority of BV–BJ
primer pairs respond concordantly to template titrations.
However, data in Figures 4 and 5 show that template can
be reduced to an amount where Cts from a minority of
BV–BJ-speciﬁc ampliﬁcations exceed the values predicted
by the template dilution resulting in a loss of representa-
tion. Since there is a wide range of representation of tran-
scripts with diﬀerent BV–BJ combinations, it is important
to select amounts of starting RNA for RT–PCRs and
bead-enriched templates for real-time PCRs that (i)
exceed the amounts required for detection of highly
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Figure 5. Eﬀects of titration of RNA template on BV–BJ-speciﬁc ampliﬁcation of b transcripts. Total RNA template from B6 splenocytes was
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Comparisons of Ct values from matched BV–BJ-speciﬁc ampliﬁcations were performed to yield distributions of Ct values and estimations of mean
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of poorly represented transcripts to maximize the obser-
vable diversity of BV–BJ combinations.
Detection ofvariable diversity
The analyses of multiple inbred mice with the BV–BJ
matrix have shown that BV–BJ combinations exhibit
only minor variations in representation in normal C57
background mice (data not shown). This relative homo-
geneity may be based in the housing of these genetically
identical mice under speciﬁc pathogen-free conditions that
do not exert signiﬁcant selective pressures on T-cell popu-
lations. The ability of the BV–BJ matrix to detect reper-
toires with reduced or skewed diversity was investigated
through the use of genetically immunocompromized mice
and populations of lymphocytes that were purposefully
mixed with monoclonal T-cells.
Immunocompromized mice included (i) NOD-scid mice
that lack B and T cells and (ii) nude mice that are athymic
but capable of low levels of extra-thymic T cell develop-
ment leading to accumulations of detectable T-cell popu-
lations with increasing age (27). Spleens were harvested
from nude mice at 16 weeks of age based on previous
observations that populations of CD4
+ and CD8
+ T
cells have accumulated by that age (27). B cells were
depleted from nude spleen cells by panning over dishes
coated with goat anti-mouse Ig. The eluted cells were
50% T cells based on ﬂow cytometric analysis using
ﬂuorochrome-labeled antibodies speciﬁc for CD3, CD8
and CD4 (data not shown). Total RNA was extracted
from these populations and analysed by the BV–BJ
matrix (Figure 6B for one representative mouse). The
results of the BV–BJ analysis of nude T cells diﬀered
from those of normal B10T cells (Figure 6A) in two
principal respects: (i) the median Ct value (23.9 cycles)
was 5.4 cycles slower than the median Ct value for
normal B10T cells and (ii) no ampliﬁcation was observed
for 20% of the BV–BJ combinations. The apparent reduc-
tion in diversity of the nude TCR repertoire was sup-
ported by Shannon entropy analysis that yielded scaled
entropy values of 0.88 and 0.73 for normal and nude T
cells, respectively. Reduced diversity in the nude BV–BJ
matrix was also indicated by the identiﬁcation of ampli-
cons from the real-time PCRs that had dissociation curves
with reduced breadth suggesting reduced complexity. Six
amplicons of this type were selected for direct sequencing
and four amplicons yielded single-copy sequences for clear
translations of the CDR3s (included in Figure 6B). Greater
reduction in BV–BJ diversity was observed through ana-
lysis of splenocytes from an NOD-scid mouse. NOD-scid
mice lack B and T cells due to a mutation in the Prkdc gene
(28) so they provide a physiological negative control for
the speciﬁcities of the BV and BJ primers. Total RNA
extracted from whole splenocyte populations were ampli-
ﬁed with the BV–BJ matrix method (Figure 6C for one
sample). Products were obtained for only six BV–BJ com-
binations with Ct values ranging from 26.4 to 39.2 cycles.
At least one of these products derived from a single tran-
script as evidenced by the ability to obtain single copy
sequence (included in Figure 6C). These six BV–BJ
primer pairs did not yield products with the second
RNA template (data not shown). These results indicated
that the ampliﬁcations in the BV–BJ matrix method
required RNA extracted from T lymphocytes.
BV1
BV2
BV3
BV4
BV5.1
BV5.2
BV6
BV7
BV8.1,2
BV8.3
BV9
BV10
BV11
BV12
BV13
BV14
BV15
BV16
BV18
BV20
Nude
CDR3s of Restricted Products
BV5.1-BJ2.4:
CASSLPGGKGQNTLY
BV7-BJ1.1:
CASSLTANTEV
BV11-BJ2.1:
CASSLEQGNYAEQ
BV13-BJ2.3:
CASSPKGFAETLY
B6 BV1 A
B
C
BV2
BV3
BV4
BV5.1
BV5.2
BV6
BV7
BV8.1,2
BV8.3
BV9
BV10
BV11
BV12
BV13
BV14
BV15
BV16
BV18
BV20
1
.
1
1
.
2
1
.
3
1
.
4
1
.
5
1
.
6
2
.
1
2
.
2
2
.
3
2
.
4
2
.
5
2
.
7
BJ Primer
1
.
1
1
.
2
1
.
3
1
.
4
1
.
5
1
.
6
2
.
1
2
.
2
2
.
3
2
.
4
2
.
5
2
.
7
BJ Primer
1
.
1
1
.
2
1
.
3
1
.
4
1
.
5
1
.
6
2
.
1
2
.
2
2
.
3
2
.
4
2
.
5
2
.
7
BJ Primer
BV1
BV2
BV3
BV4
BV5.1
BV5.2
BV6
BV7
BV8.1,2
BV8.3
BV9
BV10
BV11
BV12
BV13
BV14
BV15
BV16
BV18
BV20
NOD-scid
CDR3 of Restricted Product
BV1-BJ2.7:
CASSQDLGYEQY
Ct Range
11–15
16–20
21–25
26–30
31–35
36–40
Figure 6. Representations of 240 BV–BJ combinations in RNA
extracted from normal and immunodeﬁcient mouse spleen cells. Total
RNA was extracted from normal B10 splenocytes (A), B cell-depleted
nude mouse splenocytes (B), and NOD-scid spleen cells (C), and ampli-
ﬁed by the BV–BJ matrix method. Amplicons with relatively narrow
dissociation curves were selected for direct sequencing and the transla-
tions of single copy sequences are presented.
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derived from nude mouse T cells suggests that the BV–BJ
matrix method is capable of amplifying and identifying
overrepresented transcripts for direct sequencing. An
additional test involved the mixing of normal T-cell popu-
lations with limited numbers of monoclonal T cells prior
to total RNA extraction. Normal B6 spleen cells were
mixed in a 100:1 ratio with splenocytes from an OT-1
transgenic mouse whose T cells expressed a BV5.2–BJ2.7
rearrangement (29). Total RNA that was extracted from
the mixed cells was ampliﬁed in pooled RT–PCRs and re-
ampliﬁed by real-time PCRs. The dissociation curves for
wells combining the BV5.2 primer with the 12 BJ primers
are presented in Figure 7. The BV5.2–BJ2.7 primer pair
yielded accelerated ampliﬁcation (Ct=16 cycles) when
compared with Ct values from the other 11 BV5.2–BJ
primer pairs (19–24 cycles). Further, the dissociation
peak from the BV5.2–BJ2.7 primer pair had increased
magnitude and reduced width. This product was directly
sequenced and yielded single-copy sequence which trans-
lated into the reported OT-1 CDR3 sequence
(CASSRANYEQY). These results and those presented
above for ampliﬁcation of RNA from nude mice demon-
strate that the BV–BJ matrix has the capacity to identify
and ultimately sequence overrepresented TCR b tran-
scripts within whole populations of lymphocytes.
Restricted repertoires in rejecting skinallografts
The separate ampliﬁcations of 240 individual BV–BJ com-
binations should increase the capacity for identifying and
sequencing amplicons from overrepresented b transcripts
expressed by T-cell populations that inﬁltrate sites of
inﬂammation. The utility of the BV–BJ matrices for iden-
tifying such transcripts was investigated using a model of
skin allograft rejection. We have reported that successive
sets of skin allografts that are incompatible for a single
minor histocompatibility antigen (MiHA) are inﬁltrated
by changing populations of T cells (30). These experiments
utilized spectratyping to identify b and a transcripts that
were overrepresented at the time of allograft rejection. For
the present experiments, we harvested ﬁfth set allografts
that expressed either the H4 or HY MiHAs and were in
the process of being rejected. Total RNA was extracted
from the rejecting allografts and ampliﬁed in pooled
RT–PCRs and subsequent real-time PCRs.
The matrices from allografts harvested from two reci-
pients for each MiHA (Figures 8 and 9) indicate signiﬁ-
cantly reduced diversity in comparison to matrices from
normal T-cell populations. Speciﬁc ampliﬁcation was
observed for only 28–40% (H4) and 60–70% (HY) of
the BV–BJ combinations. Ct values were increased over
those observed with normal T cells indicating reduced
amounts of b transcript templates. In addition, the
widths of dissociation curves were highly variable in com-
parison to those same ampliﬁcations of templates from
normal mice (Figure 10) suggesting that the ampliﬁed pro-
ducts were variable in their complexity. Working under
the assumption that the most narrow dissociation peaks
included single products, sets of BV–BJ products were
selected from the matrices from single recipients for
sequencing with the respective BV primers. Single copy
sequences with productive rearrangements were obtained
for 81% of the sequenced BV–BJ products from both
H4- and HY-incompatible grafts (Tables 2 and 3). All
sequences included the expected BV sequences indicating
that the sequenced BV–BJ ampliﬁcations were at least
BV-speciﬁc. BJ identity was conﬁrmed in 92% of the
sequences derived from H4-incompatible grafts, and the
remaining sequences included shortened BJ segments.
Multiple products were observed with 13 and 12% of
the products from H4- and HY-incompatible grafts,
respectively, and 5% (H4) and 6% (HY) of the products
were non-productive rearrangements. Only 1% of the pro-
ducts could not be sequenced due to low amounts of pro-
duct. The CDR3s that were derived from the H4-
incompatible grafts were inspected for net charges and
lengths to compare them to CDR3 sequences that we
have previously obtained from multiple sets of H4-
incompatible grafts (30). The mean net charges ( 0.8)
and lengths (8.4 amino acids) were comparable to the
CDR3s previously obtained from ﬁfth set grafts.
DISCUSSION
T-cell populations must sustain suﬃcient diversity to both
maintain memory responses as well as mount eﬀective
responses by naı¨ve T cells, and the diversity of T-cell
populations is determined by the diversity of expressed
TCRs. An approach for rigorously evaluating TCR diver-
sity would expectedly oﬀer new opportunities to analyse
T-cell repertoires in individuals with compromized or
reconstituted immune systems. Such an approach should
also ﬁnd increased utility in the analysis of T-cell popula-
tions that inﬁltrate sites of autoimmunity, rejection of
70 80 90
0.18
0.13
0.03
BV5.2-BJ2.7 (from OT-1)
Ct=16 cycles
Temperature (Degrees)
11 BV5.2-BJ Pairs
Ct=19–24 cycles
Figure 7. Detection of an experimentally overrepresented transcript by
the BV–BJ matrix method. Normal B6 and transgenic OT-1 spleen cells
were mixed in a 100:1 ratio prior to the extraction of total RNA. Total
RNA template was ampliﬁed by the BV–BJ matrix method and the
dissociation curves of products ampliﬁed by pairings of the BV5.2
primer with the 12 BJ primers are presented. The BV5.2–BJ2.7 ampli-
cons were directly sequenced and the translated sequence matched the
CDR3 of the OT-1 b chain.
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information on the diversity of inﬁltrating T cells.
Spectratyping has played an essential role in these analyses
but appears to be somewhat limited in broad, clinical
applications due to a number of limitations. The method
is relatively time-consuming and generates data that are
diﬃcult to statistically evaluate since the data are spectra
of CDR3 lengths that are generated by gel electrophoresis
and are highly variable in amplitude and length distribu-
tion. The analysis of diversity has generally been per-
formed by visual inspection of the data, and a statistical
method has been reported for identifying signiﬁcant
skewing in spectratypes but not comparing diversities of
diﬀerent RNA templates (31). The identiﬁcation of over-
represented b transcripts is limited by the BV gene-speciﬁc
ampliﬁcations; with this level of resolution, the identiﬁca-
tion of a single, overrepresented transcript requires that
expression of a single BV gene be limited to a single, pre-
dominant T-cell clonotype. The eﬃciency of identiﬁcation
of overrepresented transcripts by spectratyping has been
increased by re-ampliﬁcation with BJ primers (15), but
this approach is not amenable to routine monitoring of
repertoire diversity due to cost and labor intensity.
Alternative methods have been reported for evaluating
repertoire diversity through quantitation of (i) re-anneal-
ing of amplicons from b transcripts (7,8) and (ii) hybridi-
zation of b transcript cRNAs to arrays of oligonucleotides
that are unrelated to b transcripts (9). It is certainly not
clear that the former methods can be extended to the ana-
lysis of total repertoires rather than limited subsets of b
transcripts, i.e. speciﬁc BV–BJ combinations, and the sta-
tistical methods for analyzing the data produced by these
assays have not been clearly described. Even if these lim-
itations are overcome, these methods are still restricted to
analysis of diversity of T-cell populations without any
possibility of identifying and sequencing overrepresented
transcripts.
The BV–BJ matrix method was designed to eﬃciently
analyse the diversities of b transcript repertoires and max-
imize identiﬁcation and sequencing of overrepresented b
transcripts. The use of real-time PCR instrumentation for
analysis of TCR repertoires oﬀers a number of improve-
ments in sensitivity, sample handling, data acquisition
and data analysis. First, the simultaneous monitoring of
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Figure 8. Representations of 240 BV–BJ combinations in RNA extracted from H4-incompatible skin grafts at the times of rejection by two
recipients. (A) Distributions of Ct values for individual BV–BJ-speciﬁc ampliﬁcations and (B) frequency distributions of Ct values.
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SYBR Green provides estimates of the tempo of ampliﬁ-
cation throughout entire reactions with estimations of Ct
values. Second, automated melting at the completion of
the reactions provides dissociation curves for conﬁrming
speciﬁc ampliﬁcation. These automated analyses eliminate
the additional sample handling and electrophoretic
separation required in spectratyping for identiﬁcation,
separation and quantitation of products. Third, the simul-
taneous analysis of ampliﬁcation with a single matrix of
BV–BJ primer pairs simpliﬁes data organization and sta-
tistical analysis. The dissection of b transcript repertoires
with a matrix of deﬁned BV–BJ combinations enabled us
to estimate relative b transcript diversities by Shannon
entropy that has been used previously to estimate the
variability of individual amino acid positions in the vari-
able regions of immunoglobulin heavy chains and TCR b
chains (22,32). The relatively large number of BV–BJ
primer pairs increases the sensitivity of Shannon entropy
(21), and continuous Ct values, rather than simple ‘pre-
sence’ or ‘absence’ of ampliﬁcation, increase the amount
of information in these diversity estimates. Fourth, the
increased resolution associated with 240 BV–BJ combina-
tions improves the eﬃciency of identifying and sequencing
overrepresented transcripts due to the increased number
of individual PCRs that increases the probability of iso-
lating products derived from single, prominent b tran-
scripts. Regarding the speciﬁcity of ampliﬁcation with
the BV–BJ matrix, products from 131/240 BV–BJ primer
pairs have now been sequenced with 100% ﬁdelity for BV
and BJ genes (Figures 8 and 9; and data not shown).
All 21 BV genes are represented in this set of sequenced
products, thereby conﬁrming the speciﬁcity of all nested
BV primer pairs.
In addition to these methodological advantages, the use
of BV–BJ primer pairs in real-time PCRs constitutes a
fundamentally diﬀerent approach to analyzing the diver-
sity of b transcripts expressed by T-cell populations. TCRs
recognize peptides bound by MHC molecules with speci-
ﬁcity being directed toward both MHC molecules and
bound peptides. V regions of TCR a and b subunits
bind principally to MHC molecules through CDR1 and
CDR2 regions with limited, if any, direct contact with
bound peptides, and J regions have limited contacts
with MHC+peptide (33). CDR3s in the a and b subunits
provide the major contacts with MHC-bound peptides so
CDR3 motifs and lengths are important in determining
speciﬁcity for these peptides (6,33). In fact, restriction in
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Figure 9. Representations of 240 BV–BJ combinations in RNA extracted from HY-incompatible skin grafts at the times of rejection by two female
recipients. (A) Distributions of Ct values for individual BV–BJ-speciﬁc ampliﬁcations and (B) frequency distributions of Ct values.
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characteristic to be selected in murine T cell responses
(4). Spectratyping principally focuses on evaluating reper-
toire diversity with distributions of CDR3 lengths in tran-
scripts carrying individual BV genes. The presence of
restricted or skewed distributions of CDR3 lengths are
considered to be indicative of restriction of TCR reper-
toires presumably through the presence of T clonotypes
that have expanded in responses to speciﬁc antigens.
Studies in mice and humans have shown that the majority
of predominant peaks with single CDR3 lengths are com-
prised of products ampliﬁed from multiple b transcripts
(34,35), suggesting that evaluation of repertoire diversity
by CDR3 length distribution alone could lead to under-
estimation of diversity. However, the more limited invol-
vement of BV and BJ regions in direct contacts with
MHC-bound peptides should limit the selection of indivi-
dual BV–BJ combinations in expansions of T-cell clono-
types in antigen-speciﬁc responses. T-cell subpopulations
that respond to single peptides appear to express diverse
BV and BJ combinations relative to the more restricted
CDR3 lengths and motifs, although there are a number of
peptides in experimental models that appear to stimulate
T cells with restricted BV usage (3,5). Therefore, dissection
of T-cell repertoires by estimating the distribution of
individual BV–BJ combinations should provide estimates
of repertoire diversity with reduced biases from previous
clonotypic expansions. Ampliﬁcation of b transcripts
with an array of individual BV–BJ primer pairs still
facilitates identiﬁcation of oligoclonal expansions
of T-cell clonotypes within total T-cell populations
(Figures 6 and 7).
The BV–BJ matrix method is not without its own tech-
nical diﬃculties and shortcomings. First, it does not reveal
skewing of CDR3 length distributions that may indicate
previous in vivo priming of T-cell subpopulations.
However, the products ampliﬁed in BV–BJ matrices
could certainly be electrophoretically separated to yield
spectra of CDR3 lengths within amplicon populations car-
rying single BV–BJ combinations. Second, the sensitivity
of real-time PCR analysis of TCR repertoires to amounts
of starting template and ampliﬁcation conditions requires
careful estimation of percentages of T cells and control of
ampliﬁcation conditions. Routine use of the described
method to compare levels of diversity in total T-cell popu-
lations should involve enrichment of T cells or CD4
+ and
CD8
+ subpopulations to ensure that percentages of
T cells within the populations used for RNA extractions
are consistent. Successful control over ampliﬁcation con-
ditions requires normalization, but the ampliﬁcation of
only  0.4% of available b transcripts by individual
pairs of BV–BJ primers complicates such normalization
that is routinely achieved by ampliﬁcation with primers
speciﬁc for unrelated genes that are transcribed at levels
comparable to the genes whose transcripts are being ana-
lysed. Experiments are in progress to develop rigorous
normalization methods for RT–PCRs and BV–BJ
matrices to monitor variations in ampliﬁcation conditions
by using total RNA templates that are diluted to yield Ct
values that are comparable to those obtained with BV–BJ
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Figure 10. Dissociation curves from products of BV–BJ-speciﬁc amplications of total RNA from normal splenocytes and rejecting allografts.
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the use of negative control cells, e.g. ﬁbroblasts, to con-
ﬁrm speciﬁcity of ampliﬁcation and detect any cross-
contamination.
The data presented in Figure 5 show that extended dilu-
tions of total RNA templates may result in speeds of
ampliﬁcation that are slower than expected for the range
of dilutions, and the numbers of BV–BJ combinations
that exhibit such decreased ampliﬁcation increase with
extended dilutions. These dilution eﬀects would also be
expected with spectratyping but may be diﬃcult to identify
given that electrophoretic separations of products with
complex and variable length distributions complicate ana-
lysis. It follows that direct comparisons of TCR repertoire
diversities in whole T-cell populations versus tissue-
inﬁltrating T cells should be avoided unless the latter lym-
phocytes are enriched before total RNA extraction. Such
comparisons have been previously reported to show T-cell
oligoclonality in biopsies of human inﬂammatory sites
Table 3. Amino acid sequences of b CDR3s that are overrepresented
in HY-incompatible skin grafts at the time of rejection by a single
recipient (HY1)
BV–BJ pair BV–CDR3–BJ sequence
BV1–BJ1.5 CASS QEGGI QAPLFGEGTRLSVL
BV1–BJ2.4 CASS QGGIN QNTLYFGAGTRLSV
BV2–BJ1.3 CSA TEV SGNTLYFGEGSRLIVV
BV2–BJ1.4 CS GNGQG SNERLFFGHGTKLSVL
BV2–BJ1.5 CSA QG NNQAPLFGEGTRLSVL
BV2–BJ2.4 CRA GRRG SQNTLYFGAGTRLSVL
BV3–BJ1.1 CASS LSQ NTEVFFGKGTRLTVV
BV3–BJ2.2 CASS RTD TGQLYFGEGSKLTVL
BV3–BJ2.7 CASS LNRG EQYFGPGTRLTVL
BV5.1–BJ2.1 CASS LNWGD AEQFFGPGTRLTVL
BV5.1–BJ2.2 CASS LSGY TGQLYFGEGSKLTVL
BV5.1–BJ2.5 CASW G NQDTQYFGPGTRLLVL
BV5.2–BJ1.5 CASS PDS NNQAPLFGEGTRLSVL
BV5.2–BJ2.3 CASS LGGA SAETLYFGSGTRLTVL
BV5.2–BJ2.5 CASS RTV NQDTQYFGPGTRLLVL
BV6–BJ1.2 CASS MGQEA SDYTFGSGTRLLVI
BV6–BJ2.1 CASS RGS YAEQFFGPGTRLTVL
BV6–BJ2.2 CASS LPGG TGQLYFGEGSKLTVL
BV7–BJ1.1 CASS FSRS NTEVFFGKGTRLTVV
BV7–BJ2.7 CASS WGWR YEQYFGPGTRLTVL
BV8.1–BJ2.2 CASS DRSD TGQLYFGEGSKLTVL
BV8.2–BJ1.4 CASA RDT NERLFFGHGTKLSVL
BV8.2–BJ2.3 CASG GTT SAETLYFGSGTRLTVL
BV8.3–BJ1.2 CASS DAH SDYTFGSGTRLLVI
BV8.3–BJ1.5 CASS RES NQAPLFGEGTRLSVL
BV8.3–BJ2.1 CASS DEDWA YAEQFFGPGTRLTVL
BV9–BJ1.4 CASS TGGAA NERLFFGHGTKLSVL
BV9–BJ2.3 CASR RRGR AETLYFGSGTRLTVL
BV10–BJ1.5 CASS DRY NNQAPLFGEGTRLSVL
BV10–BJ1.6 CASR RTF SYNSPLYFAAGTRLTVT
BV10–BJ2.7 CASS YP YEQYFGPGTRLTVL
BV11–BJ1.3 CASS NRGL GNTLYFGEGSRLIVV
BV11–BJ1.4 CASS LVERSK ERLFFGHGTKLSVL
BV11–BJ2.3 CASR AGGS SAETLYFGSGTRLTVL
BV12–BJ1.5 CASS LGR NQAPLFGEGTRLSVL
BV12–BJ2.1 CASS LSGGD AEQFFGPGTRLTVL
BV12–BJ2.4 CASS TQ SQNTLYFGAGTRLSVL
BV13–BJ1.2 CASS LTG NSDYTFGSGTRLLVI
BV13–BJ2.1 CASS FWGD YAEQFFGPGTRLTVL
BV13–BJ2.5 CASS FTG QDTQYFGPGTRLLVL
BV14–BJ1.5 CAWR QRV NNQAPLFGEGTRLSVL
BV14–BJ1.6 CAWS RG SYNSPLYFAAGTRLTVT
BV14–BJ2.1 CAWS RRV NYAEQFFGPGTRLTVL
BV14–BJ2.5 CAWS LRLGA QDTQYFGPGTRLLVL
BV15–BJ1.3 CGA RDRVF GNTLYFGEGSRLIVV
BV15–BJ1.4 CGAG QGT NERLFFGHGTKLSVL
BV15–BJ1.6 CGA RDG YNSPLYFAAGTRLTVT
BV18–BJ1.2 CSSR DSA NSKYTFGSGTRLLVI
BV18–BJ1.4 CSSR GTGRG ERLFFGHGTKLSVL
BV18–BJ2.1 CSSR ANS YAEQFFGPGTRLTVL
BV18–BJ2.7 CSSR GGC YEQYFGPGTRLTV
BV20–BJ1.1 CSSS LQG TEVFFGKGTRLTVV
BV20–BJ1.6 CSSS QLAD NSPLYFAAGTRLTVT
BV20–BJ2.5 CSSS QRTGGR DTQYFGPGTRLLV
Table 2. Amino acid sequences of b CDR3s that are overrepresented in
H4-incompatible skin grafts at the time of rejection by a single recipient
(H41)
BV–BJ pair BV–CDR3–BJ sequence
BV1–BJ2.3 CASS LDWGG AETLYFGSGTRLTVL
BV1–BJ2.4 CASS SQDWG QNTLYFGAGTRLSVL
BV1–BJ2.7 CASS SDRV QYFGPGTRLTVL
BV2–BJ1.1 CSA DRPGAS TEVFFGKGTRLTVV
BV2–BJ1.4 CSA GTT NERLFFGHGTKLSVL
BV2–BJ2.1 CS V NYAEQFFGPGTRLTVL
BV2–BJ2.5 CSA DCS QDTQYFGPGTRLLVL
BV3–BJ1.2 CASS RT NSDYTFGSGTRLLVI
BV3–BJ1.4 CAG TGGP NERLFFGHGTKLSVL
BV3–BJ2.1 CASS LSGR AEQFFGPGTRLTVL
BV3–BJ2.7 CASS LGDD EQYFGPGTRLTVL
BV5.1–BJ1.2 CASS QG NSDYTFGSGTRLLVI
BV5.1–BJ1.4 CASS LERG SNERLFFGHGTKLSVL
BV5.1–BJ2.1 CASS PGLG YAEQFFGPGTRLTVL
BV5.1–BJ2.4 CASS LALGG SQNTLYFGAGTRLSVL
BV5.1–BJ2.7 CASS LAGGG YEQQFGPGTRLTVL
BV6–BJ1.1 CASS FGQGA EVFFGKGTRLTVV
BV6–BJ1.2 CASS IRD SDYTFGSGTRLLVI
BV6–BJ2.1 CASS IRD NYAEQFFGPGTRLTVL
BV7–BJ1.1 CASP QVA NTEVFFGKGTRLTVV
BV7–BJ2.5 CASS PGQG DTQYFGPGTRLLVL
BV8.1–BJ2.1 CASS DQGD YAEQFFGPGTRLTVL
BV8.1–BJ2.5 CASS GTG QDTQYFGPGTRLLVL
BV8.2–BJ1.5 CASG VQGG NQAPLFGEGTRLSVL
BV8.2–BJ2.3 CASG DLGG SAETLYFGSGTRLTVL
BV8.3–BJ1.1 CASS DGTV EVFFGKGTRLTVV
BV8.3–BJ1.2 CASR GPA NSDYTFGSGTRLLVI
BV8.3–BJ2.2 CASS E NTGQLYFGEGSKLTVL
BV8.3–BJ2.4 CASS DWGF QNTLYFGAGTRLSVL
BV9–BJ2.5 CASS RDTGAR DTQYFGPGTRLLVL
BV10–BJ1.3 CASS GRS SGNTLYFGEGSRLIVV
BV10–BJ2.2 CASS LDWR NTGQLYFGEGSKLTVL
BV11–BJ1.1 CASS LGNA NTEVFFGKGTRLTVV
BV11–BJ1.3 CASS LGT SGNTLYFGEGSRLIVV
BV11–BJ2.3 CASS PGTG AETLYFGSGTRLTVL
BV11–BJ2.4 CASS LEPD SQNTLYFGAGTRLSVL
BV12–BJ1.2 CASS S NSDYTFGSGTRLLVI
BV12–BJ1.3 CASS DRA GNTLYFGEGSRLIVV
BV12–BJ1.5 CASS WTG NQAPLFGEGTRLSVL
BV12–BJ2.4 CASS LD SQNTLYFGAGTRLSVL
BV12–BJ2.5 CASS LYE DTQYFGPGTRLLVL
BV13–BJ1.1 CASS PRDR NTEVFFGKGTRLTVV
BV13–BJ1.4 CASS LQGD NERLFFGHGTKLSVL
BV13–BJ2.5 CASS LWGD QDTQYFGPGTRLLVL
BV14–BJ1.1 CAWS PPGT NTEVFFGKGTRLTVV
BV14–BJ1.2 CAWS LPGQGD SDYTFGSGTRLLVI
BV15–BJ2.1 CGAR DRQ NYAEQFFGPGTRLTVL
BV15–BJ2.4 CGAR GR QNTLYFGAGTRLSVL
BV16–BJ1.1 CASS QANK EVFFGKGTRLTVV
BV18–BJ1.6 CSS NNRG YNSPLYFAAGTRLTVT
BV18–BJ2.3 CS PRDWGA SAETLYFGSGTRLTVL
BV20–BJ1.2 CSSS WDRA SDYTFGSGTRLLVI
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Although those analyses most certainly identiﬁed overre-
presented transcripts, TCR diversity may have been
under-estimated given that enrichments of inﬁltrating
T cells were not performed.
The BV–BJ matrices are presently being developed for
analysis of repertoires of human T-cell populations.
Humans express 47 BV genes and 13 BJ genes (37), and
these numbers require increased attention to the design of
BV-speciﬁc nested primers since the majority of BV genes
are closely related members of subfamilies (37). The result-
ing matrices of 611 individual BV–BJ combinations will
provide even greater resolution than the mouse matrices
and increase the eﬃciency of identifying and sequencing b
transcripts from sites of T-cell inﬁltration. We believe that
BV–BJ matrices have the potential to accelerate the ana-
lyses of T-cell repertoires in humans and animal models
through their technical simplicity, increased levels of reso-
lution and uncomplicated statistical analysis.
ACKNOWLEDGEMENT
The authors gratefully acknowledge the assistance of
Ms DeAnn Frederixon for graphic presentations.
FUNDING
Funding for open access charge: Mayo Clinic Funds.
Conﬂict of interest statement. None declared.
REFERENCES
1. Chien,Y.H., Gascoigne,R.J., Kavaler,J., Lee,N.E. and Davis,M.M.
(1984) Somatic recombination in a murine T-cell receptor gene.
Nature, 309, 322–326.
2. McHeyzer-Williams,M.G. and Davis,M.M. (1995) Antigen-speciﬁc
development of primary and memory T cells in vivo. Science, 268,
106–111.
3. Kedzierska,K., La Gruta,N.L., Davenport,M.P., Turner,S.J. and
Doherty,P.C. (2005) Contribution of T cell receptor aﬃnity to
overall avidity for virus-speciﬁc CD8
+ T cell responses. Proc. Natl
Acad. Sci. USA, 102, 11432–11437.
4. McHeyzer-Williams,L.J., Panus,J.F., Mikszta,J.A. and McHeyzer-
Williams,M.G. (1999) Evolution of antigen-speciﬁc T cell receptors
in vivo: preimmune and antigen-driven selection of preferred
complementarity-determining region 3 (CDR3) motifs. J. Exp.
Med., 189, 1823–1837.
5. Zhong,W. and Reinherz,E.L. (2004) In vivo selection of a TCR Vb
repertoire directed against an immunodominant inﬂuenza virus
CTL epitope. Intl Immunol., 16, 1549–1559.
6. Garcia,K.C., Degano,M., Pease,L.R., Huang,M., Peterson,P.A.,
Teyton,L. and Wilson,I.A. (1998) Structural basis of plasticity in
T cell receptor recognition of a self peptide-MHC antigen. Science,
279, 1166–1172.
7. Wagner,U.G., Koetz,K., Weyand,C.M. and Goronzy,J.J. (1998)
Perturbation of the T cell repertoire in rheumatoid arthritis. Proc.
Natl Acad. Sci. USA, 95, 14447–14452.
8. Baum,P.D. and McCune,J.M. (2006) Direct measurement of T-cell
receptor repertoire diversity with AmpliCot. Nat. Methods, 3,
895–901.
9. Ogle,B.M., Cascalho,M., Joao,C., Taylor,W., West,L.J. and
Platt,J.L. (2003) Direct measurement of lymphocyte receptor
diversity. Nucleic Acids Res., 31, e139.
10. Pannetier,C., Cochet,M., Darche,S., Casrouge,A., Zoller,M. and
Kourilsky,P. (1993) The sizes of the CDR3 hypervariable regions of
the murine T-cell receptor b chains vary as a function of the
recombined germ-line segments. Proc. Natl Acad. Sci. USA, 90,
4319–4323.
11. DePalma,R. and Gorsky,J. (1995) Restricted and conserved T-cell
repertoires involved in allorecognition of class II major
histocompatibility complex. Proc. Natl Acad. Sci. USA, 92,
8836–8840.
12. Caignard,A., Dietrich,P., Morand,V., Lim,A., Pannetier,C.,
Leridant,A.M., Hercend,T., Even,J., Kourilsky,P. and Triebel,F.
(1994) Evidence for T-cell clonal expansion in a patient with
squamous cell carcinoma of the head and neck. Cancer Res., 54,
1292–1297.
13. Musette,P., Bequet,D., Delarbre,C., Gachelin,G., Kourilsky,P. and
Dormont,D. (1996) Expansion of a recurrent Vb5.3+ T-cell
population in newly diagnosed and untreated HLA-DR2 multiple
sclerosis patients. Proc. Natl Acad. Sci. USA, 93, 12461–12466.
14. Guillet,M., Brouard,S., Gagne,K., Sebille,F., Cuturi,M.C.,
Delsuc,M.A. and Soulillou,J.P. (2002) Diﬀerent qualitative and
quantitative regulation of Vb TCR transcripts during early acute
allograft rejection and tolerance induction. J. Immunol., 168,
5088–5095.
15. Pannetier,C., Levraud,J.P., Lim,A., Even,J. and Kourilsky,P. (1997)
The immunoscope approach for the analysis of T cell repertoires.
In Oksenberg,J.R. (ed), The Antigen T cell Receptor: Selected
Protocols and Applications, R.G. Landes Company, Georgetown,
TX, pp. 287–325.
16. Yassai,M., Naumova,E. and Gorski,J. (1997) Generation of TCR
spectratypes by multiplex PCR for T cell repertoire analysis.
In Oksenberg,J. R. (ed), The Antigen T Cell Receptor: Selected
Protocols and Applications, R.G. Landes Company, Georgetown,
TX, pp. 326–372.
17. Sriram,U., Wong,M., Caillier,S.J., Hecht,F.M., Elkins,M.K.,
Levy,J.A., Oksenberg,J.R. and Baranzini,S.E. (2007) Quantitative
longitudinal analysis of T cell receptor repertoire expression in
HIV-infected patients on antiretroviral and interleukin-2 therapy.
AIDS Res. Human Retroviruses, 23, 741–747.
18. Manuel,E.R., Charini,W.A., Sen,P., Peyerl,F.W., Kuroda,M.J.,
Schmitz,J.E., Autissier,P., Sheeter,D.A., Torbett,B.E. and
Letvin,N.L. (2006) Contribution of T-cell receptor repertoire
breadth to the dominance of epitope-speciﬁc CD8
+ T-lymphocyte
responses. J. Virol., 80, 12032–12040.
19. Wysocki,L.J. and Sato,V.L. (1978) ‘‘Panning’’ for lymphocytes: a
method for cell selection. Proc. Natl Acad. Sci. USA, 75, 2844–2848.
20. Bailey,D.W. and Usama,B. (1960) A rapid method of grafting skin
on tails of mice. Transplant. Bull., 7, 424–428.
21. Shannon,C.E. (1948) The mathematical theory of communication.
Bell Syst Tech J, 27, 379–423, 623–656.
22. Litwin,S. and Jores,R. (1992) Shannon information as a measure
of amino acid diversity. In Perelson,A.S. and Weisbuch,G. (eds),
Theoretical and Experimental Insights into Immunology, Springer,
Berlin.
23. Vacchio,M.S. and Hodes,R.J. (1989) Selective decreases in T cell
receptor Vb expression - decreased expression of speciﬁc Vb families
is associated with expression of multiple MHC and non-MHC gene
products. J. Exp. Med., 170, 1335–1346.
24. Pullen,A.M., Potts,W., Wakeland,E.K., Kappler,J. and Marrack,P.
(1990) Surprisingly uneven distribution of the T cell receptor Vb
repertoire in wild mice. J. Exp. Med., 171, 49–62.
25. Candeias,S., Waltzinger,C., Benoist,C. and Mathis,D. (1991) The
Vb17
+ T cell repertoire: Skewed Jb usage after thymic selection;
dissimilar CDR3s in CD4
+ versus CD8
+ cells. J. Exp. Med., 174,
989–1000.
26. Kato,T., Suzuki,S., Sasakawa,H., Masuko,K., Ikeda,Y.,
Nishioka,K. and Yamamoto,K. (1994) Comparison of the Jb gene
usage among diﬀerent T cell receptor Vb families in spleens of
CD57BL/6 mice. Eur. J. Immunol., 24, 2410–2414.
27. Kennedy,J.D., Pierce,C.W. and Lake,J.P. (1992) Extrathymic T cell
maturation. Phenotypic analysis of T cell subsets in nude mice as
a function of age. J. Immunol., 148, 1620–1629.
28. Bosma,M., Schuler,W. and Bosma,G. (1988) The scid mouse
mutant. Curr. Top. Microbiol. Immunol., 137, 197–202.
29. Hogquist,K.A., Jameson,S.C., Heath,W.R., Howard,J.L.,
Bevan,M.J. and Carbone,F.R. (1994) T cell receptor antagonist
peptides induce positive selection. Cell, 76, 17–27.
PAGE 15 OF16 Nucleic Acids Research, 2008, Vol. 36,No. 21 e14030. Wettstein,P.J., Strausbauch,M. and Borson,N.D. (2007) Repertoires
of T cell receptors expressed by graft-inﬁltrating T cells evolve
during long-term recall responses to single minor histocompatibility
antigens. Int. Immunol., 19, 523–534.
31. Killian,M.S., Matud,J., Detels,R., Giorgi,J.V. and Jamieson,B.D.
(2002) MaGiK method of T cell receptor repertoire analysis. Clini.
Vacc. Immunol., 9, 858–63.
32. Stewart,J.J., Lee,C., Ibrahim,S., Watts,P., Shlomchik,M.,
Weigert,M. and Litwin,S. (1997) A Shannon entropy analysis of
immunoglobulin and T cell receptor. Mol. Immunol., 34, 1067–1082.
33. Colf,L.A., Bankovich,A.J., Hanick,N.A., Bowerman,N.A.,
Jones,L.L., Kranz,D.M. and Garcia,K.C. (2007) How a single T cell
receptor recognizes both self and foreign MHC. Cell, 129, 135–146.
34. Naumov,Y.N., Hogan,K.T., Naumova,E.N., Pagel,J.T. and
Gorski,J. (1998) A class I MHC-restricted recall response to
a viral peptide is highly polyclonal despite stringent CDR3 selec-
tion: Implications for establishing memory T cell repertoires in
‘‘real-world’’ conditions. J. Immunol., 160, 2842–2852.
35. Sourdive,D.J.D., Murali-Krishna,K., Altman,J.D., Zajac,A.J.,
Whitmire,J.K., Pannetier,C., Kourilsky,P., Evavold,B., Sette,A. and
Ahmed,R. (1998) Conserved T cell receptor repertoire in primary
and memory CD8 T cell responses to an acute viral infection.
J. Exp. Med., 188, 71–82.
36. Puisieux,I., Even,J., Pannetier,C., Jotereau,F., Favrot,M. and
Kourilsky,P. (1994) Oligoclonality of tumor-inﬁltrating lymphocytes
from human melanomas. J. Immunol., 153, 2807–2818.
37. Giudicelli,V., Chaume,D. and Lefranc,M.P. (2005) IMGT/GENE-
DB: a comprehensive database for human and mouse
immunoglobulin and T cell receptor genes. Nucleic Acids Res., 33,
D256–D261.
e140 Nucleic Acids Research, 2008, Vol. 36, No. 21 PAGE 16 OF16